Pharmacom Labs Anastrozolos 1mg

Pharmacom Labs Anastrozolos 1mg | Oral Anastrozole Tablets

Pharmacom Labs Anastrozolos is an orally active, non-steroidal Type II Aromatase Inhibitor (AI) containing 1mg of Anastrozole per unit dose. Functioning through selective and competitive binding to the heme iron of the cytochrome P450 aromatase ($CYP19A1$) enzyme, Anastrozolos inhibits the peripheral rate-limiting conversion of circulating androgenic substrates into estrogens (estradiol and estrone).

By reducing serum estradiol concentrations by up to 80% at standard dosages, Anastrozolos effectively controls estrogenic signaling at target receptor sites while maintaining adrenal steroidogenesis, leaving cortisol and aldosterone production uncompromised.

Manufactured by Pharmacom Labs under stringent quality control and laboratory production guidelines, each batch is tested for analytical purity and accurate active ingredient concentration. Store at controlled room temperature (15°C to 25°C), shielded from light, excessive heat, and direct moisture.

Product Attribute Table